Satomi Tanaka
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Recurrence of Large-Vessel Vasculitis Induced by Multiple Types of Granulocyte Colony-Stimulating Factor Preparation in Patient with Large-Cell Neuroendocrine Lung Carcinoma: A Case Report.
Journal: Case reports in oncology
Published: March 22, 2023
Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 11, 2022
Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non-small cell lung cancer.
Journal: Cancer medicine
Published: August 06, 2022
Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: January 04, 2022
Impact of maintenance therapy following induction immunochemotherapy for untreated advanced non-small cell lung cancer patients.
Journal: Journal of cancer research and clinical oncology
Published: September 01, 2021
The Treatment of Cancer Cachexia
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: August 17, 2021
Prognostic factors in older patients with wild-type epidermal growth factor receptor advanced non-small cell lung cancer: a multicenter retrospective study.
Journal: Translational lung cancer research
Published: February 11, 2021
Cachexia and Sarcopenia Associated with Lung Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 03, 2020
Impact of preexisting antinuclear antibodies on combined immunotherapy and chemotherapy in advanced non-small cell lung cancer patients.
Journal: Medical oncology (Northwood, London, England)
Published: September 08, 2020
Significance of inflammatory indexes in atezolizumab monotherapy outcomes in previously treated non-small-cell lung cancer patients.
Journal: Scientific reports
Published: May 30, 2020
Erlotinib as standard adjuvant therapy for resectable EGFR mutation-positive non-small cell lung cancer.
Journal: Translational lung cancer research
Published: February 11, 2020
Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.
Journal: BMC infectious diseases
Published: January 09, 2019
Last Updated: 09/26/2026